# Pharmacokinetics of PN-235 in Healthy Volunteers

> **NCT04621630** · PHASE1 · COMPLETED · sponsor: **Protagonist Therapeutics, Inc.** · enrollment: 107 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PN-235
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04621630
- **Lead sponsor:** Protagonist Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-12
- **Primary completion:** 2021-09-19
- **Final completion:** 2021-10-13
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04621630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04621630, "Pharmacokinetics of PN-235 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04621630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*